Influenza a and influenza b
Pro Research Analysisby 
Searched over 200M research papers
Influenza A and Influenza B: A Comparative Analysis
Overview of Influenza A and B Viruses
Influenza is a highly contagious respiratory illness caused by influenza A and B viruses. These viruses are responsible for annual seasonal epidemics, with influenza A also being involved in sporadic pandemic outbreaks due to its zoonotic origins . The World Health Organization estimates that annual influenza epidemics result in approximately 1 billion infections, 3-5 million severe cases, and 300,000-500,000 deaths globally .
Clinical Characteristics and Severity
Similarities in Clinical Presentation
Studies have shown that the clinical symptoms of influenza A and B are largely similar. Both types can cause acute respiratory infections with symptoms such as fever, cough, and sore throat . Despite minor differences in symptom distribution, the overall clinical illness produced by both virus types is indistinguishable among patients consulting general practitioners .
Differences in Severity and Outcomes
However, there are notable differences in the severity and outcomes of infections caused by these two virus types. Influenza B has been associated with higher mortality rates compared to influenza A, particularly in pediatric populations. For instance, a Canadian study found that the mortality rate for influenza B was significantly higher than for influenza A among children under 16 years of age 25. Additionally, influenza B infections have been linked to higher risks of hospitalization and ICU admissions, especially in older children 25.
Epidemiology and Circulation Patterns
Seasonal Variability
Influenza A and B viruses exhibit different patterns of circulation. Influenza A is more commonly associated with pandemics and tends to evolve more rapidly due to higher mutation rates . In contrast, influenza B viruses evolve more slowly and are often seen as the dominant strain every four to five years . Both types co-circulate during seasonal epidemics, but influenza B is more prominent in certain years .
Geographic and Age Distribution
In the Asia-Pacific region, influenza B has been identified as a significant cause of morbidity across all age groups, with a higher incidence in children aged 1-10 years . The co-circulation of both B lineages (Yamagata and Victoria) has been documented, although mismatches between vaccine strains and circulating strains are common .
Vaccine and Antiviral Strategies
Vaccine Formulation and Efficacy
Influenza vaccines are formulated annually to match the circulating strains of both influenza A and B. However, the efficacy of these vaccines can be suboptimal, especially in cases of antigenic mismatch . The development of quadrivalent vaccines, which include both lineages of influenza B, is recommended to provide broader protection .
Antiviral Treatments
Antiviral agents targeting the neuraminidase enzyme of the influenza virus are available for both prophylaxis and treatment. However, their use remains limited, and emerging approaches such as universal influenza vaccines are being explored to offer protection against a wider range of influenza viruses .
Genetic and Evolutionary Insights
Mutation Rates and Reassortment
Influenza A viruses have a higher mutation rate compared to influenza B, contributing to their rapid evolution and ability to cause pandemics . Reassortment, a process where genetic segments are exchanged between viruses, occurs frequently within types but not between influenza A and B due to incompatible viral packaging signals . This genetic divergence helps maintain the distinct identities of these virus types .
Co-infections
Co-infections with both influenza A and B viruses are rare but have been documented, particularly in immunocompromised patients. These co-infections can complicate the clinical management and may influence the epidemiology and evolution of influenza viruses .
Conclusion
Influenza A and B viruses, while similar in many clinical aspects, exhibit distinct differences in severity, epidemiology, and genetic evolution. Understanding these differences is crucial for developing effective vaccines and treatment strategies to mitigate the impact of influenza on public health.
Sources and full results
Most relevant research papers on this topic
When “B” becomes “A”: the emerging threat of influenza B virus
Influenza B virus has become a significant contributor to the annual flu season, with increased potency in causing severe disease and mortality, refuting the claim that it is the milder version of the flu.
Comparative Severity of Influenza A and B Infections in Hospitalized Children
Influenza A and B infections have similar clinical severity in children, suggesting the need for quadrivalent vaccines containing both lineages of B viruses for optimal protection against severe influenza illnesses.
Influenza A and B Virus Intertypic Reassortment through Compatible Viral Packaging Signals
The lack of influenza A and B virus reassortants is partially due to incompatibilities in virus-specific packaging signals, which hinder segment incorporation into nascent virions.
Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel.
Influenza A(H1N1)pdm 2009 and influenza B virus co-infections were found in immunocompetent patients during the 2015-2016 epidemic season in Israel, suggesting a rare but potentially important phenomenon in influenza virus epidemiology, pathogenicity, and evolution.
DOI